Moneycontrol Be a Pro
Get App
you are here: HomeNewsBusiness
Last Updated : Dec 03, 2019 12:41 PM IST | Source: PTI

Zydus receives tentative USFDA approval for Lorcaserin Hydrochloride Tabs

The company has received tentative approval from United States Food and Drug Administration (USFDA) to market the tablets in the strength of 10 mg, Zydus Cadila said in a filing to BSE.

Representative image
Representative image

Drug firm Zydus Cadila on Tuesday said that it has got a tentative approval from the US health regulator to market Lorcaserin Hydrochloride Tablets used in the treatment of obesity.

The company has received tentative approval from United States Food and Drug Administration (USFDA) to market the tablets in the strength of 10 mg, Zydus Cadila said in a filing to BSE.

The drug will be manufactured at the Group's formulations manufacturing facility at the Gujarat SEZ.

Close

The group now has 278 approvals and has so far filed over 330 abbreviated new drug applications (ANDAs) since the commencement of the filing process in 2003-04.

Shares of Cadila Healthcare, the listed entity of Zydus Group were today trading at Rs 255.15, down 1.16 per cent on the BSE.

LIVE NOW... Video series on How to Double Your Monthly Income... where Rahul Shah, Ex-Swiss Investment Banker and one of India's leading experts on wealth building, reveals his secret strategies for the first time ever. Register here to watch it for FREE.
First Published on Dec 3, 2019 12:35 pm
Loading...
Follow us on
Available On